Exophiala jeanselmei peritonities in a patient on CAPD.
Remon
C
C
de la Calle
I J
IJ
Vallejo Carrion
F
F
Perez-Ramos
S
S
Fernández Ruiz
E
E
D000935:Antifungal Agents / Q000627:therapeutic use; D002404:Catheterization / Q000009:adverse effects / Q000295:instrumentation; D004866:Equipment Contamination; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D003904:Mitosporic Fungi; D009181:Mycoses / Q000175:diagnosis* / Q000188:drug therapy; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects* / Q000295:instrumentation; D010538:Peritonitis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*
D000935:Antifungal Agents; D015725:Fluconazole; D005437:Flucytosine